Book Test to Release
In order to come out of quarantine early you may need a Test to Release certificate. Please note it typically takes 12-18 hours to process samples from the time they reach the lab.Test to Release
Book Fit to Fly
Fit to Fly Tests are often required in case you need to travel to certain countries. Please note it typically takes 12-18 hours to process samples from the time they reach the lab.Fit to Fly
Strategy based solution
Create a clear strategy for allowing employees to safely return to work.
Get customers and visitors back through your doors.
Offer home-testing solutions for remote employees, or set up a provision in the workplace.
Plan and support
Instil confidence in staff with clear guidance, safety measures and ongoing support.
Continuously keep monitoring and provide rapid response to combat local outbreaks.
How we can help
We create solutions tailored to the needs of your business, whether your teams are remote or need to be office-based.
Swab Testing – Presence of Virus
This test can indicate the presence of a live virus in an individual. These tests are great for early identification and stopping outbreaks.
We offer remote lab testing and point of care solutions. All testing machines and consumables are CE IVD accredited with high detection rates.
This is a highly accurate NHS standard swab test to identify if someone currently has COVID-19. Test samples are processed in a lab, which takes 6-24 hours to get the results.
A 10 minute test using a swab sample to identify if an individual has COVID-19. It requires no lab equipment and can be done on site.
COVID-19 Antibody Testing
Team members may have developed antibodies and should be tested before they can return to work.
Antibody Lab Based Test
This lab based test detects the presence of COVID-19 antibodies in the blood. These are Abbott ELISA based tests that have been approved by NHS for testing of antibodies.
Antibody Point of Care Test
As part of our offering, we are able to peform local antibody tests in empty office spaces using portable equipment. These are quick tests that last only 12-20 minutes.
Welcome your team back with ease
COVID-19 Risk Management Portal
Use the portal to understand your risk exposure and track symptoms of your staff and/or visitors.
Understand Risk Exposure
Get regular updates and view how many of your staff have symptoms, are high risk, have had the virus and developed antibodies or have tested positive.
One way to reduce risk is to get more data and facts. Through the portal, you are able to request swab tests or antibody tests and automatically receive results as soon as they become available.
Where available, we are able to integrate with your HR systems or provide bolt-on track & trace solution to give better visibility and risk management.
We offer a tailored, integrated solution to help businesses reopen safely, with additional high quality services.
At Agilis, our research team use trends and developments from the UK and beyond to make informed and aware decisions. We have worked with businesses in the South Korean biotech industry for a number of years and have crafted close working relationships. Businesses in this sector are globally renowned for delivering consistently high quality, reliable products and we are proud of our links to the industry.
We believe that our end to end solution is the most comprehensive in terms of helping companies get back to business as usual.
Get in touch today
What are the different types of COVID-19 tests?
There are two main types of test:
Antigent Test: this tests for the presence of a virus in a sample. There are ranges of tests in this category from ‘gold standard’ tests that are done by an accredited lab to more of screening solutions that require little to no equipment and are able to provide results in 8-30 minutes
Antibody Tests: this tests whether someone has developed antibodies and had the virus previously.
What does an antibody test involve?
There are two different types of Antibody tests:
1) Lab based Antibody test- a test kit is used to gather blood from a patient which is then tested in the lab. These are usually referred to as ELISA tests. They are extremely accurate and able to let you know if you had the virus and developed antibodies as a result of this.
2) Blood prick tests- these test kits can be used by trained professional to determine at point of care whether you had the virus. A small blood prick is taken and used in a cartridge to do the diagnostic.
Can you test people at my workplace?
Yes, we provide a number of solutions from regular lab based testing to developing regular screening programmes.
In the first instance we propose designing and agreeing clinical governance approach to workplace testing and then we provide a solution to support this.
Can you offer remote-only testing?
Yes, we have a number of remote solutions if you decide you only want to do ad-hoc testing.
Current mutation of SARS Cov-2: D614G SARS COV-2
Mutated position by SNPs (single nucleotide polymorphism)
Nucleotide change at 23,403 base of RNA from adenosine (A) to guanine (G)
Mutated at D614 on the Spike Protein (SP)
enhancing the binding affinity to ACE2 receptor
no mutation on the nucleocapid protein (NP) of Sars Cov-2
In summary this has no impact on our ability to successfully detect covid-19
The Agilis Health refund policy is as follows:
- If the sample pack has not been dispatched at the time of cancellation a full refund can be offered
- If the sample pack has been dispatched, the pack can be returned and the order cancelled with a fee of £50 plus VAT being applied. The refund will be offered, minus the cancellation fee of £50 plus VAT
- Once the sample pack has been used to take a sample, or has been tampered with, full costs remain and no cancellation or refund is available.
- Where applicable, referring to the above conditions, refund amounts will appear in your bank account 7 days after receipt of the returned sealed untampered sample pack
Test to Release – best time to book tests
Please note if you are booking Test to Release, the earliest that the sample can be collected is during the course of day 5 of your quarantine, with day 1 commencing from the time that you arrive in the UK. This means that you are able to book a test on day 1 of quarantine, get pack in time and arrange a video call appointment for day 5. This would allow us to get the sample to the lab the day following your test and then issue your result typically within 12-18 hours of it getting to the lab (guaranteed within 24 hours of the sample getting to the lab).
Fit to Fly
Many governments and airlines require that a test for COVID-19 be taken prior to travelling. The rules differ by government and airline and some accept antigen tests, some only accept PCR tests and there is little consistency as to the timeline requirement for the test result, but typically it is 48-72 hours prior to travel. Please check specific requirements prior to booking the Fit to Fly test.
Where is the clinic?
Typically Agilis operates a home service. Our service includes a video call with one of our nurses that is able to guide you through the sample collection process. As such we are able to offer our service nationwide.
Further Guidance for Test to Release
From 4am on 9th January, should you be travelling to the UK from Namibia, Zimbabwe, Botswana, Eswatini, Zambia, Malawi, Lesotho, Mozambique, Angola, Mauritius or Seychelles, then as per government advice you should self-isolate for 10 days upon entry to the UK and should not take a test to release test during this period.
In addition, from 4am on 15th January, should you be travelling to the UK from Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Cape Verde, Portugal (including Madeira and the Azores) and Panama, then as per government advice you should self-isolate for 10 days upon entry to the UK and should not take a test to release test during this period.
As of 4am on 29th January, the same travel restrictions as above will apply for Burundi, UAE and Rwanda and anyone who has travelled from any of these countries should not participate in the test to release scheme.